Completed PHASE4 INTERVENTIONAL 2-arm NCT03110029

Evaluating the Efficacy and Compatibility of Efinaconazole 10% Solution (Jublia) for the Treatment of Toenail Onychomycosis in Patients Wearing Toenail Polish Compared to Those Without Polish

Sponsor: University of Alabama at Birmingham

Interventions Application of Nail Polish Efinaconazole 10% Topical Application Solution [JUBLIA]

Updated 8 times since 2017 Last updated: Jun 21, 2019 Started: Sep 30, 2015 Primary completion: May 31, 2017 Completion: Jul 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Onychomycosis of Toenail, this trial is completed. The trial is conducted by University of Alabama at Birmingham and has accumulated 8 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jul 2019 — Jan 2021 [monthly]

Completed PHASE4
Apr 2019 — Jul 2019 [monthly]

Completed PHASE4

Status: Active Not Recruiting → Completed

▶ Show 3 earlier versions

Jun 2018 — Apr 2019 [monthly]

Active Not Recruiting PHASE4
Feb 2018 — Jun 2018 [monthly]

Active Not Recruiting PHASE4
May 2017 — Feb 2018 [monthly]

Active Not Recruiting PHASE4

First recorded

Sep 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Alabama at Birmingham

Data source: University of Alabama at Birmingham

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Birmingham, United States